177Lu-TLX591

· Telix Pharmaceuticals (Innovations) Pty Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 177Lu-TLX591, covering 2025-07-10 to 2025-07-10. Get the full timeline:

Most recent: Clinical Trial Update: The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global) [Phase 3]